by David Sires | Jul 7, 2026 | Blog
The LinkedIn article titled “Trinity Health Aims to Improve Liver Cancer Screening Rates Through Physician, Patient Education Intervention” highlights a small but potentially high-impact initiative by Trinity Health West Michigan to improve hepatocellular...
by David Sires | Jul 1, 2026 | Blog
The PharmaVoice article titled “3 late-stage MASH drugs that could rival Rezdiffra” highlights the next wave of MASH therapies expected to compete with Madrigal’s Rezdiffra (resmetirom), emphasizing that the future of MASH treatment will likely...
by David Sires | Jun 25, 2026 | Blog
This LinkedIn post highlights a major milestone by the Beth Israel Deaconess Medical Center (BIDMC) Transplant Institute.”The robotic approach brought a new dimension to an already complex operation led by transplant surgeons Drs. Martin Dib and Vincenzo Villani...
by David Sires | Jun 21, 2026 | Blog
Summary: “Why Are Liver Cancer Rates Rising in the U.S.?” (AARP) The video explains that liver cancer rates in the United States have tripled over the past 40 years, with a major driver being the rise in obesity and fatty liver disease. Historically, viral hepatitis...
by David Sires | Jun 10, 2026 | Blog
The article titled “New study reveals turbocharged GLP-1 drug helps shed body weight and fat in the liver” delineates a VCU Health report on survodutide, a next-generation obesity/liver disease drug that combines GLP-1 agonism (similar to Ozempic/Wegovy)...
